Silfurberg primarily invests in startups in the healthcare and pharmaceutical sectors, with a preference for companies that are 11-15 years old. Some notable startups in their portfolio include Oculis. They typically invest in rounds with 3-4 participants and often collaborate with other venture capital firms such as Brunnur Ventures and Pivotal bioVenture Partners. The fund has been most active in 2016 and typically invests in deals ranging from $10-50 million. However, they have a relatively low deal frequency, usually participating in less than 2 deals per year.